ENT Devices Market Global Report 2017

ENT Devices Market Global Report 2017

  • July 2017 •
  • 250 pages •
  • Report ID: 4693466 •
  • Format: PDF
ENT devices are used for diagnosis, surgery and treatment of any kind of diseases related to ear, nose and throat and thereby correct the problems related to hearing, snoring, smelling or speaking. Diseases can include hear loss, chronic ear disease, airway stenosis, airway tumors, cancer, feeding and swallowing disorders, mastoiditis, voice disorders (Dysphonia), sinusitis and others. Some of the popular ENT devices available in the market are endoscopes, hearing aids, hearing implants, handheld surgical instruments, balloon sinus dilation devices, CO2 lasers, image-guided surgery systems, ear tubes, and voice prosthesis devices.

Asia was the largest region in the ENT devices market in 2016, accounting for around 37% of the market share. The Americas was the second-largest region accounting for around 34% of the market share. Europe was the third-largest region accounting for around 21% of the market share.

Companies in the ENT device market are working towards constant innovation in design and technology to make these devices more user friendly and non-invasive. They are continuously investing funds and resources into R&D to increase the scope of their devices. For instance, Intersect ENT developed Propel Mometasone Furoate Implant (PMFI) to treat chronic sinusitis. It is a bio-absorbable steroid which is placed directly into the sinus mucosa. It controls the release of drugs and dissolves over time. In another breakthrough in sinusitis treatment, SinuSys Corporation got FDA approval for its Vent-Os Sinus Dilation device. It is a small, low-pressure insert that is designed to gently open the sinus ostia and use the body’s natural mucosal fluids to expand the device